Submitted:
26 March 2025
Posted:
28 March 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
1.1. Siddha: A Revered System of Traditional Medicine
1.1.1. Chooranas in Siddha Medicines [7]
1.2. Oral Disintegrating Tablet
1.2.1. Objective
1.2.2. Ideal Properties of Oral Disintegrating Tablet
1.2.3. Merits of Oral Disintegrating Tablet
2. Discussion
3. Materials and Methods
3.1. Preparation of Chooranam
3.1.2. Salient Features of Herbal APIs (Chooranam) and Excipients [18]
3.2. Preparation Methods of ODTs
3.2.1. Direct Compression
3.2.1.1. Key Aspects
3.2.2. Freeze Drying [23]
3.2.2.1. Key Aspects
3.2.3. Molding [24]
3.2.3.1. Key Aspects
3.2.4. Sublimation
3.2.4.1. Key Aspects
3.2.5. Spray Drying
3.2.5.1. Key Aspects
3.2.6. Cotton Candy Process
3.2.6.1. Key Aspects
3.2.7. Mass Extrusion
3.2.7.1. Key Aspects
3.3. Quality Control Test
3.3.1. For Herbal Drug
3.3.1.1. Authentication Study [29]
3.3.1.2. HPTLC
3.3.2. For Formulated ODTs
3.3.2.1. Pre Compression Parameters [51].
3.3.2.1.1. Bulk Density
3.3.2.1.2. Tapped Density
3.3.2.1.3. Flow Rate
3.3.2.1.4. Carrs Index
3.3.2.1.5. Hausners Ratio [32]
| Compressibility Index | Flowability | Hausner’s Ratio |
|---|---|---|
| 5–15 | Excellent | 1.05–1.18 |
| 12–16 | Good | 1.14–1.20 |
| 18–21 | Fair-passable | 1.22–1.26 |
| 21–33 | Poor | 1.30–1.54 |
| 33–37 | Very poor | 1.50–1.61 |
| >40 | Very-very poor | >1.61 |
Hausner ratio = Tapped density/Bulk density
3.3.2.1.6. Angle of Repose [33]
| Angle of repose | Flowability |
|---|---|
| <25° | Excellent flow |
| 25–30° | Good |
| 30–40° | Satisfactory or passable |
| 40–50° | Poor |
| >50° | Very poor or damp |
3.3.2.1.7. FTIR Study
3.3.2.2. Post Compression Tablet Parameter3.3.2.2.1. Organoleptic Characteristics
3.3.2.2.2. Weight Variation
| Weight average (mg) | Max SD. |
|---|---|
| Less than 85mg | 10 |
| 85mg – 250mg | 7.5 |
| Greater than 250 | 5 |
3.3.2.2.3. Hardness and Thickness [36]
3.3.2.2.4. Friability
3.3.2.2.5. Disintegration Test
3.3.2.2.6. Wetting Time (Wt) and Water Absorption Ratio (R)
3.3.2.2.7. Taste/Mouth Sensation Test
3.3.2.2.8. Moisture Uptake
3.3.2.2.9. Invitro Disintegration Study [41]
3.3.2.2.10. In-Vivo Disintegration Test
3.3.2.2.11. In-Vitro Dissolution Test [42]
3.3.2.2.12. Drug Content
3.3.2.2.13. Stability Study
4. Conclusions
Funding
Acknowledgments
Conflicts of Interest
Abbreviations
| ODT | Orally Disintegrating Tablet |
| API | Active Pharmaceutical Ingredients |
| BD | Bulk Density |
| TD | Tapped Density |
References
- Karmegam, D.; Prakash, M.; Karkalan, N.; Bagavandas, M. Development of database structure and indexing for Siddha medicine system: A platform for Siddha literature analytics. Dialogues Health 2022, 1, 100008. [Google Scholar] [PubMed]
- Mukherjee, K.P. Evaluation of Indian Traditional Medicine. Drug Information Journal 2001, 35, 623–632. [Google Scholar]
- Karunamoorthi, K.; Jegajeevanaram, K.; Xavier, J.; Jayaraman, N.; Melita, L. Tamil Traditional Medicinal System—A SiddhaIndigenous Health Practice in the International Perspectives. E-Tang 2012, 2.
- Mutheeswaran, S.; Pandikumar, P.; Chellappandian, M.; Ignacimuthu, S. Documentation and Quantitative Analysis of the Local Knowledge on Medicinal Plants Among Traditional Siddha Healers in Virudhunagar District of Tamil Nadu, India. Journal of Ethnopharmacology 2011, 137, 523–533. [Google Scholar] [PubMed]
- Sujeethasai, K. Pharmacological Analysis of Sivathai Chooranam (Polyherbal Formulation) in Siddha Medicine: A Literature Review. International Journal of Recent Scientific Research 2020, 11, 38494–38497. [Google Scholar]
- Manimekalai, K.; Aswini, P.; Nalina Saraswathi, K.; Saravana Devi, M.D.; Velpandian, V. Standardisation and physiochemical evaluation of the drug Raja Elathi Chooranam – A Siddha polyherbal formulation. Int. J. Health Sci. Res. 2020, 12. [Google Scholar]
- The Siddha Formulary of India, (1992). Part I, First Edition, Formulary – Chapter No.21. Curanams, Published by Department of Health, Ministry of Health and Family Welfare, Govt. of India, New Delhi, 151-156.
- Al Khattawi, A.; Mohammed, A.R. Compressed orally disintegrating tablets, excipients, evolution, and formulation strategies. Expert Opin. Drug Deliv. 2013. [Google Scholar]
- Krupa, A.; Jachowicz, R.; Pędzich, Z.; Wodnicka, K. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems. AAPS PharmSciTech 2012, 13. [Google Scholar] [CrossRef]
- Stegemann, S.; Gosh, M.; Breitkrentz, J. Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. Int. J. Pharm. 2012, 430, 197–206. [Google Scholar]
- Chinwala, M. Recent formulation advances and therapeutic usefulness of orally disintegrating tablets (ODTs). Pharmacy 2020, 8, 186. [Google Scholar] [CrossRef]
- Shukla, D.; Chakraborthy, S.; Sanjay, S.; Brahmeshwar, M. Mouth dissolving tablets I: An overview of formulation technology. Scientia Pharm. 2009, 77, 309–326. [Google Scholar]
- Nand, P.; Vashis, N.; Anand, A.; Sushma, D. Mouth dissolving tablets: A novel drug delivery system. Int. J. Appl. Biol. Pharm. Technol. 2010, 1, xx. [Google Scholar]
- Dinesh Kumar, P.; Tajaswi, V.; Dhatrija, K. Fast dissolving tablets: An overview. Int. J. Res. Pharm. Sci. 2012, 3, 348–355. [Google Scholar]
- Rakesh, P.; Mona, P.; Prabodh, C.S.; Dhirendar, K.; Sanju, N. Orally disintegrating tablets: Friendly to pediatrics and geriatrics. Arch. Appl. Sci. Res. 2020, 2, 35–48. [Google Scholar]
- Wilson, G.C.; Washington, N.; Peach, J.; Murray, R.G.; Kennerley, J. The behavior of a fast dissolving dosage form (Expidet) followed by γ-scintigraphy. Int. J. Pharm. 1987, 40, 119–123. [Google Scholar]
- Seager, H. Drug delivery products and the Zydis fast dissolving dosage form. J. Pharm. Pharmacol. 1997, 50, 375–382. [Google Scholar]
- Poursharifi Ghourichay, M.; Kiaie, S.H.; Nokhodchi, A.; Javadzadeh, Y. Formulation and quality control of orally disintegrating tablets (ODTs): Recent advances and perspectives. Biomed. Res. Int. 2021, 6618934, 12. [Google Scholar] [CrossRef]
- Nagar, P.; Singh, K.; Chauhan, I.; et al. Orally disintegrating tablets: Formulation, preparation techniques, and evaluation. J. Appl. Pharm. Sci. 2011, 1, 35–45. [Google Scholar]
- Chowdary, K.; Suchitra, B. Recent research on orodispersible tablets – A review. Int. Res. J. Pharm. Appl. Sci. 2014, 4, 63–73. [Google Scholar]
- Liang, A.C.; Chen, L.-L.H. Fast-dissolving intraoral drug delivery systems. Expert Opin. Ther. Patents 2001, 11, 981–986. [Google Scholar]
- Jeganathan, N.S.; Kannan, K.; Manavalan, R.; Vasanthi, H.R. Standardization of a Siddha formulation Amukkara Curanam by HPTLC. Afr. J. Trad. CAM 2008, 5, 131–140. [Google Scholar]
- Omar, S.; AbdAlla, F.; Abdelgawad, N. Effect of mannitol on Physical characters of lyophilized fast-disintegrating tablets. J. Adv. Pharm. Res. 2017, 1, 228–233. [Google Scholar] [CrossRef]
- Kumar, R.; Patil, M.B.; Patil, S.R.; Paschapur, M.S. Development and characterization of melt-in-mouth tablets of haloperidol by sublimation technique. Int. J. Pharm. Pharm. Sci. 2009, 1, 65–73. [Google Scholar]
- Kasper, J.C.; Friess, W. The freezing step in lyophilization: Physico-chemical fundamentals, freezing methods, and consequences on process performance and quality attributes of biopharmaceuticals. Eur. J. Pharm. Biopharm. 2011, 78, 248–263. [Google Scholar] [CrossRef] [PubMed]
- Mishra, D.N.; Bimodal, M.; Singh, S.K.; Vijaya, K. Spray dried excipient base: A novel technique for the formulation of orally disintegrating tablets. Chem. Pharm. Bull. 2006, 54, 99–102. [Google Scholar] [CrossRef]
- Badgujar, B.; Mundada, A. The technologies used for developing Orally disintegrating tablets: A review. Acta Pharm. 2011, 61, 117–139. [Google Scholar] [CrossRef]
- Gryczke, A.; Schminke, S.; Maniruzzaman, M.; Beck, J.; Douroumis, D. Development and evaluation of orally disintegrating tablets (ODTs) containing ibuprofen granules prepared by hot melt extrusion. Colloids Surf. B: Biointerfaces 2011, 86, 275–284. [Google Scholar] [CrossRef]
- Sima, I.A.; Andrási, M.; Sârbu, C. Chemometric Assessment of Chromatographic Methods for Herbal Medicines Authentication and Fingerprinting. Journal of Chromatographic Science. 2018, 56, 49–55. [Google Scholar] [CrossRef]
- Ansari, M.J.; Ahmad, S.; Kohli, K.; Ali, J.; Khar, R.K. Stability-Indicating HPTLC Determination of Curcumin in Bulk Drug and Pharmaceutical Formulations. J. Pharm. Biomed. Anal. 2005, 39, 132–138. [Google Scholar] [CrossRef]
- Thakur, D.; Sharma, R. Solid Dispersion: A Novel Approach for Enhancement of Solubility and Dissolution Rate: A Review. Indian J. Pharm. Biol. Res. 2019, 7, 7–14. [Google Scholar] [CrossRef]
- Yoshio, K.; Masazumi, K.; Shuichi, A.; Hiroaki, N. Evaluation of Rapidly Disintegrating Tablets Manufactured by Phase Transition of Sugar Alcohols. J. Control. Release 2005, 105, 16–22. [Google Scholar]
- Kushekar, B.S. Mouth Dissolving Tablets: A Novel Drug Delivery System. Pharma Times 2003, 35. [Google Scholar]
- Ayub, S.; Hanif, S.; Inzamam ul Huq, U.; Irfan, M.; Ali, I.; Madkhali, O.A.; Farzana, K.; Syed, M.A.; Shahid, N.; Aftab, T.; Asmatullah, M. Pre and Post Characterization of ODTs with Emphasis on Compression Force and Quality of Super-Disintegrants: In Vivo Analysis in Healthy Volunteers. Pak. J. Pharm. Sci. 2023, 36, 1767–1775. [Google Scholar] [PubMed]
- Irfan, M.; Rabel, S.; Bukhtar, Q.; Qadir, M.I.; Jabeen, F.; Khan, A. Orally Disintegrating Films: A Modern Expansion in Drug Delivery System. Saudi Pharm. J. 2015. [CrossRef]
- Ibrahim, M.A.; Abou el Ela, A.E.S.F. Optimized Furosemide Taste Masked Orally Disintegrating Tablets. Saudi Pharm. J. 2017, 25, 1055–1062. [Google Scholar] [PubMed]
- Puttewar, T.; Kshirsagar, M.; Chandewar, A.; et al. Formulation and Evaluation of Orodispersible Tablet of Taste Masked Doxylamine Succinate Using Ion Exchange Resin. J. King Saud Univ. Sci. 2010, 22, 229–240. [Google Scholar]
- Akdag, Y.; Gulsun, T.; Izat, N.; Cetin, M.; Oner, L.; Sahin, S. Evaluation of Preparation Methods for Orally Disintegrating Tablets. Med. Sci. Int. Med. J. 2020, 9, 265–269. [Google Scholar]
- Shirai, Y.; Sogo, K.; Yamamoto, K.; Kolma, K.; Fujoka, H.; Makita, H.; Nakamura, Y. A Novel Fine Granule System for Masking Bitter Taste. Pharm. Res. Soc. Jpn. 1992, Received July 20, 1992.
- Li, M.; Zhang, T.; Zhu, L.; et al. Liposomal Andrographolide Dry Powder Inhalers for Treatment of Bacterial Pneumonia via Anti-Inflammatory Pathway. Int. J. Pharm. 2017, 528, 163–171. [Google Scholar] [PubMed]
- Koner, J.S.; Rajabi-Siahboomi, A.R.; Missaghi, S.; et al. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets. Sci. Rep. 2019, 9, 1–9. [Google Scholar]
- Cirri, M.; Rangoni, C.; Maestrelli, F.; Corti, G.; Mura, P. Development of Fast-Dissolving Tablets of Flurbiprofen-Cyclodextrin Complexes. Drug Dev. Ind. Pharm. 2005, 31, 697–707. [Google Scholar]
- Chaudhari, P.D.; Chaudhari, S.P.; Kolhes, R.; Dave, K.V. Formulation and Evaluation of Fast Dissolving Tablets of Famotidine. Indian Drugs 2005, 42, 641–649. [Google Scholar]
- Zhao, N.; Augsburger, L.L. Functionality Comparison of 3 Classes of Superdisintegrants in Promoting Aspirin Tablet Disintegration and Dissolution. AAPS PharmSciTech 2005, 6, E634–E640. [Google Scholar] [CrossRef]
- Thulluru, A.; Palei, N.N.; Vimala, M.; Vidyasagar, M.; Vishnupriya, K. Quality by Design Approach to Optimize the Taste Masked Zolpidem Tartrate Oral Disintegrating Tablets. Res. J. Pharm. Dosage Forms Technol. 2018, 10, 139–148. [Google Scholar] [CrossRef]
- Umalkar, D.G.; Shinde, G.V.; Bangale, G.S.; Rajesh, K.S.; Murthy, R.S. Design and Evaluation of Orodispersible Tablet of Aceclofenac Using Different Superdisintegrants by 2³ Factorial Designs. Res. J. Pharm. Dosage Forms Technol. 2010, 2, 198–203. [Google Scholar]
- Elkhodairy, K.A.; Hassan, M.A.; Afifi, S.A. Formulation and Optimization of Orodispersible Tablets of Flutamide. Saudi Pharm. J. 2014, 22, 53–61. [Google Scholar] [CrossRef]
- Kamboj, M.; Goyal, S.; Rakha, P.; et al. Formulation and Evaluation of Metformin Orodispersible Tablets. Acta Pol. Pharm. 2011, 68, 717–723. [Google Scholar]
- Arun Raj, R.; Harindran, D.J. Formulation and Evaluation of Carvedilol Solid Dispersion Tablets for Solubility Enhancement. Eur. J. Biomed. Pharm. Sci. 2017, 4, 337–348. [Google Scholar]
- Rane, R.D.; Gulve, N.H.; Patil, V.V.; Thakare, M.V.; Patil, R.V. Formulation and Evaluation of Fast Dissolving Tablet of Albendazole. Int. Curr. Pharm. J. 2012, 1, 311–316. [Google Scholar] [CrossRef]
- Onkar, D.; Manojkumar, P. Development and Evaluation of Fast Dissolving Tablets of Diltiazem Hydrochloride. Int. J. Res. Ayurveda Pharm. 2015, 6, 493–501. [Google Scholar]
| Excipients | Function | Example |
|---|---|---|
| Super disintegrant | It produces rapid disintegration anddissolution rate. In the presence of other ingredients like water soluble excipiets and effervescent agents furtherenhances the disintegration process. | Microcrystalline cellulose Crospovidone, sodium starch gpycolate, carboxyl methyl cellulose, pregelatinated starch [19]. |
| Binder | Maintains the integrity strength of tablet until administration | PVP, Hydroxy propyl methyl cellulos, poly vinyl alcohol |
| Filler | Increases bulkiness of tablet | Sugar and sugar based derivatives (Maltos, mannitol, lactilol, xylitol) |
| Surface active agents | Enhances solubilization and reduces interfacial tension of ODT. | Starch hydrolysate, sodium doecylsulfate, sodium lauryl sulphate [20]. |
| Lubricants | Reduces the friction between the punchesand enhances bulkiness of the tablet | Magnesium stearate, zinc state, Poly ethyleneglycol, magnesium lauryl sulphate [21]. |
| Sweetner | Masking the unpleasant taste the tabletsbacts as taste masker | Sucralose, aspartame, sodiumsaccharine |
| Flavors | Enhances the patient compliance and acceptability | Peppermint, clove oil, anise oil, citrus oils, fruit essences [19]. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).